Search:
Login:
OR

Medical Marijuana

Help Stop Government from Issuing Exclusive License for Medical Cannabis

Category: Medical Marijuana | Posted on Mon, December, 19th 2011 by THCFinder
As you well know, our federal government maintains that marijuana has “no currently accepted medical use” as a schedule I substance per the Controlled Substance Act. Although sixteen states and the District of Columbia have now passed medical marijuana legislation, the Department of Justice (DOJ) continues to enforce federal law and prosecute those who cultivate, distribute, or possess medical marijuana in compliance with state law.
 
While the DOJ intimidates and incarcerates medical marijuana patients based upon federal position that cannabis has no medical value, another cabinet-level department within the federal executive branch, the Department of Health and Human Services (HHS), holds the legal right to certain medical applications of cannabinoids; since October 2003, the United States of America, as represented by the Department of Health and Human Services, has been official assignee of U.S. Patent #6630507, entitled “Cannabinoids as antioxidants and neuroprotectants. ” The Union of Medical Marijuana Patients (UMMP) has been well aware of this outrageous hypocrisy for several years now.
 
However, recent developments beg immediate attention and action from the broader community of medical marijuana advocates, as well as from all Americans who disagree with government-driven financial exploitation and monopolization of the very plant for which hundreds of thousands of American citizens are currently incarcerated.
 
The notion that one federal bureaucracy claims ownership rights to medical marijuana while its sister department prosecutes the patients who depend upon this government patented “invention” is outrageous enough. However, the Union of Medical Marijuana Patients discovered this week that the federal government now intends to grant an exclusive license to “practice the invention embodied in U.S. Patent 6,630,507” to a single New York based pharmaceutical corporation. In accordance with regulations that dictate how exclusive licenses may be granted on Government owned inventions, 37 CFR part 404.7 (a)(1) (i), the HHS published notice of its intentions in the November 17th edition of the Federal Register.
 
With a posting entitled “Prospective Grant of Exclusive License: Development of Cannabinoid(s) and Cannabidiol(s) Based Therapeutics to Treat Hepactic Encephalopathy in Humans,” the Department of Health and Human Services announced its plan to grant KannaLife Sciences, Inc. an exclusive license to “development and sale of cannabinoid(s) and cannabidiol(s) based therapeutics as antioxidants and neuroprotectants for use and delivery in humans. ”
 

Comments

Local cannabis company announces success with cancer treatment

Category: Medical Marijuana | Posted on Thu, December, 15th 2011 by THCFinder
Denver-based Cannabis Science, Inc. announced this week that a cancer patient has had success using the company’s cannabis-based product in the treatment of skin cancer.
 
The biotech company, which develops pharmaceutical cannabis products, said this is the second patient to use the product successfully. “This patient has photo-documented dramatic results that we will release to the public once treatment is completed and has been properly vetted by clinical biopsy,” the company said in a press release. “Cannabis Science, in conjunction with several Colorado-licensed dispensaries and physicians, consults with a number of cancer patients who were seeking to inform themselves of the current peer-reviewed scientific literature, regarding modern and historical use of cannabis preparations for treating cancers so that they can make informed decisions regarding their self-directed cancer treatment.”
 
More from the press release:
 
Cannabis has an outstanding safety profile as determined in 1988 by Federal Administrative Law Judge Francis Young who recommended cannabis be removed from Schedule I. The refusal of the DEA to follow this recommendation has resulted in 16 states allowing some form of medical marijuana access for their citizens. Numerous other states are moving in this direction. Consequently, patients in states with medical marijuana laws are able to make an informed decisions to try various state-legal cannabis preparations and to determine what is most effective for their particular condition. As a result, there is an unprecedented accumulation of “anecdotal” data
 
Currently, there are a variety treatments available for treating various skin cancers including standard surgical excision (Mohs Surgery), chemotherapy, radiation, and cryosurgery. Unfortunately for many, the cancer frequently returns and requires additional treatments. Chemo and radiation therapy are typically used by patients who aren’t candidates for surgery (i.e. where surgical excision could disfigure or make it difficult to reconstruct the excised area). If reoccurrence occurs, radiation therapy is often not repeated as it may further damage the tissue (and) lead to resistance.
 
While the above treatments may to be effective for many, few patients would choose to go through surgical procedures, radiation, or chemotherapy if a better alternative were available. Patients self-administering cannabis extracts in the convenience of their own home appear to be effectively resolving their cancerous lesions over a period of a few weeks to a few months.
 
Cannabis Science is committed to making cannabis-based medicines available to the public as rapidly as possible. The Company is taking multiple approaches to accomplishing this aim in the United States. The science of cannabinoids has exploded over the past decade, laying the scientific foundation for the many medicinal uses of this unique plant. Cannabinoids are a class of biologically active compounds produced by all vertebrates (endocannabinoids) the Cannabis plant (phytocannabinoids), and more recently patentable synthetic compounds produced by chemists. Today’s modern peer-reviewed science supports the many historical uses that were discovered over thousands of years of medicinal use by herbalists.
 

Comments

Thousands of Colo. marijuana applications on hold

Category: Medical Marijuana | Posted on Mon, December, 12th 2011 by THCFinder
DENVER | Some 4,200 medical marijuana applications in Colorado are on hold at the state health department while investigators look at possible fraud.
 
The Colorado Department of Public Health and Environment announced Friday that marijuana registry applications from certain physicians are on hold after law enforcement officials witnessed potential patients being seen by someone other than a physician. Colorado law requires a "bona fide" doctor-patient relationship before a physician can recommend marijuana pot for certain ailments.
 
The health department did not say which doctors were under investigation, or how law enforcement came to find out about the possible fraud. The agency said only that certain physicians would be contacted to confirm they examined would-be patients and signed their recommendations.
 
State lawmakers tightened physician requirements for medical marijuana cards in 2010 after concerns about possible fraud. Colorado now requires that a physician perform a personal physical examination of a would-be patient, keep records of the visit and offer follow-up care.
The health department said Friday that the applicants on hold will receive an answer by the end of January.
 
The head of the department, Dr. Chris Urbina, acknowledged in a statement Friday that some patients have seen lengthy delays. But he said the review is necessary to make sure all the pending recommendations meet medical muster.
"The investigation was necessary to maintain the integrity of the Medical Marijuana Registry," Urbina's statement said.
 
Urbina went on, "The exposure of this fraud should lead marijuana registry applicants to take care to ensure that they are seen and examined by a physician if they intend to apply to the medical marijuana registry."
 

Comments

VIDEO: Polis questions AG Holder on Medical Marijuana

Category: Medical Marijuana | Posted on Mon, December, 12th 2011 by THCFinder


Comments

Eric Holder okay with lawful MMCs, but do threats remain?

Category: Medical Marijuana | Posted on Fri, December, 9th 2011 by THCFinder
This week, Congressman Jared Polis quizzed U.S. Attorney General Eric Holder about the Department of Justice's approach to medical marijuana; see a video of the exchange below. For the most part, Holder suggested that MMJ businesses following state law are not Department of Justice priorities, despite recent crackdowns in California and elsewhere. Attorney Jessica Peck sees positives in his responses, but also areas of concern for the industry.
 
Peck, a lawyer and political strategist for Henley Public Affairs, is a fan of Polis's. "I've spoken with him, and I'm very impressed with how he talks with all the different stakeholders and works with everyone, including Republicans," she says. "I think he went into the committee hearing trying to get points from all perspectives, which is what a congressman should do."
 
​Regarding Holder's responses to Polis's questions, she calls them "fascinating, because you have the White House now saying it stands behind its previous position as outlined in the Ogden memo" -- a 2009 document penned by Deputy Attorney General David Ogden, which directed U.S. Attorneys not to target medical marijuana businesses in states where they're legal as long as they're following state law.
 
This summer, a memo by another deputy attorney general, James Cole "articulated a different position" than did the Ogden directive, Peck believes. In it, Cole wrote that while "it is likely not an efficient use of federal resources to focus enforcement efforts on individuals with cancer or other serious illnesses who use marijuana as part of a recommended treatment regiment consistent with applicable state law, or their caregivers," he stressed that the term "caregiver" means "individuals providing care to individuals with cancer or other serious illnesses, not commercial operations cultivating, selling or distributing marijuana." In other words, a dispensary isn't a caregiver.
 
Given this apparent shift, Peck was cheered when Holder said the Ogden memo is still current. That shows "the White House is standing behind its original position," she feels, "and that's significant. And I also thought Holder's wording was interesting. It was clear he didn't know a lot about Colorado's system. But he did say it's the federal government's position that so long as people are acting in conformity with state law, the feds don't see it as a law enforcement priority. That's different from what was previously said, which called for 'unambiguous compliance.'
 

Comments

Weed Wars: Watch a 5-Year Old Use Medical Marijuana Tonight

Category: Medical Marijuana | Posted on Fri, December, 9th 2011 by THCFinder
A few common schools of thought persist in the medical marijuana debate -- on one end, doubters point to young men at dispensaries and say that the drug is widely abused by people who are "not that sick." On the other hand, believers say that you don't need to be on death's door to benefit from medicine. And isn't Oxycontin prescription heroin, anyway?
 
A scene bound to engender even more controversy over medical marijuana will be broadcast on national television tonight, when a father will administer medical marijuana to his 5-year-old epileptic son for the first time in front of film crews for the Discovery Channel's Weed Wars.
 
Proposition 215 recommendations and marijuana use have been good enough reasons for Child Protective Services to take children away from their pot-smoking parents. So then, is giving an admittedly sick kid pot on TV such a good idea?
 
As its PR machine informed the world, Weed Wars followed around the world of Harborside Health Center for a few months, filming a day in the life of the nation's largest cannabis dispensary and its charismatic CEO, Steve DeAngelo. 
 
In this case, DeAngelo's crew recommended medical marijuana for a desperate "single father", Jason, whose son, Jayden, began experiencing hour-long seizures at the age of four months. The child is given what some might call the devil's weed via a few drops of CBD-laden tincture administered under the tongue. CBD, we may remind you, is the cannabinoid that is associated with non-intoxicating, healing properties; the medical student to its partying roommate, THC.
 
The first episode aired last week, and the second comes on tonight at 10 on the Discovery Channel. Check your local listings, or break down and order cable (or, like us, just get to know someone who has it).
 
Tales of children who are hospitalized after inadvertently eating marijuana-laden brownies or cookies have been in the mainstream media recently. But often neglected in the marijuana debate is whether -- like Ritalin -- medical cannabis is okay for children to consume.
 
In fact, it was the specter of kids smoking pot legally that caused opponents of the drug to pounce in 1996, when Prop. 215 was passed. And indeed, stiff criminal penalties for those using pot in front of children have been floated even by medical marijuana advocates -- included in Prop. 19 last year, supported by DeAngelo, for example.
 
However, at least one other sick child -- 2-year-old Cash Hyde who suffered a brain tumor -- has been given medical cannabis as a healing agent -- and it worked, according to his father.  
 
So if a father's last resort was medical marijuana and it worked to heal his son, what's the harm? 
 
 

Comments


Search








Blog Categories

Popular Articles

Latest Offers In Your Area
Recent Blog Posts
Download Our App!
September 1, 2014 | Category: Nugs
September 1, 2014 | Category: News
September 1, 2014 | Category: Fun
Mobile Apps
Copyright 2014 THCFinder.com
All Rights Reserved.
Dispensaries      Strains      About Us      Friends      API / Widgets      Privacy Policy      Terms of Use      Investors      Contact Us